Dr Manuela Klingler-Hoffmann is passionate about making a difference to cancer patients’ lives. She uses proteomics to analyse patient-derived samples with the long-term goal to assists clinicians in their therapy decisions. She is an experienced cell biologist and biochemist with a background in biophysics and the recipient of multiple fellowships and awards, such as the 2020 Winnovation award in the Science category.
Since joining the University of South Australia in 2017, she is leading a small and dedicated team working on translational research projects in collaboration with multiple industry partners. In addition, she leads multidisciplinary teams, which develop disruptive laboratory solutions for personalised medicine and... Read more
About me
Dr Manuela Klingler-Hoffmann is passionate about making a difference to cancer patients’ lives. She uses proteomics to analyse patient-derived samples with the long-term goal to assists clinicians in their therapy decisions. She is an experienced cell biologist and biochemist with a background in biophysics and the recipient of multiple fellowships and awards, such as the 2020 Winnovation award in the Science category.
Since joining the University of South Australia in 2017, she is leading a small and dedicated team working on translational research projects in collaboration with multiple industry partners. In addition, she leads multidisciplinary teams, which develop disruptive laboratory solutions for personalised medicine and novel sample preparation for mass spectrometry.
Dr Manuela Klingler-Hoffmann is passionate about gender equity and was a member of the University of South Australia self-assessment team for SAGE (http://u.unisa.edu.au/about/sage-pilot).
After finishing her PhD in 1999 at the German Cancer Research Centre in Heidelberg, Germany, she has been awarded a prestigious DFG (German Research Foundation) fellowship to work at Monash University in Melbourne. After her time at Monash University, she has been working part time in several laboratories around the world and had several career interruptions. In 2016 she was the recipient of a Barbara Kidman Fellowship, which aims to enhance and promote the career of female academics. She has co-supervised more than a dozen Honour’s students and PhD students and numerous vacation scholarship students; with multiple winning internal and external awards, such as the University medal for best the PhD thesis in Biological Sciences.
About me
Doctor of Natural Sciences University of Saarland
Bachelor of Science in Biology University of Saarland
Research
Excludes commercial-in-confidence projects.
Enabling personalised medicine for patients with ovarian cancer, Tour de Cure Ltd, 01/11/2021 - 31/12/2022
CIA Klingler-Hoffmann, CIB MacGregor, CIC Kirby Mentor: Whittle, $22,709
CIA Klingler-Hoffmann, CIB Blencowe, Mentor: Hilder, $38,000
CIA Klingler-Hoffmann, CIB Blencowe, CIC Whittle, $40,000
CIA Condina, CIB Klingler-Hoffmann, CIC Plush, $39,657
CIA Klingler-Hoffmann, CIB Whittle, CIC Blencowe Mentor: Hilder $31,124
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2024 |
Open access
6
|
| 2023 |
Open access
1
|
| 2023 |
Open access
5
|
| 2023 |
Open access
1
|
| 2022 |
Open access
1
1
2
|
| 2022 |
Open access
3
3
7
|
| 2021 |
Open access
22
16
|
| 2021 |
Open access
10
4
|
| 2021 |
Open access
14
13
1
|
| 2020 |
Open access
4
3
|
| 2020 |
Open access
10
10
8
|
| 2020 |
Open access
10
7
4
|
| 2020 |
Open access
5
3
2
|
| 2019 |
Open access
14
8
2
|
| 2019 |
10
10
6
|
| 2019 |
Open access
8
6
3
|
| 2019 |
Open access
12
10
3
|
| 2018 |
Open access
17
13
1
|
| 2017 |
Open access
216
176
6
|
| 2017 |
21
20
1
|
| 2016 |
Open access
26
19
1
|
| 2016 |
Open access
23
21
11
|
| 2016 |
Open access
20
18
10
|
| 2016 |
Open access
6
6
4
|
| 2016 |
Open access
12
9
7
|
| 2015 |
9
9
|
| 2015 |
7
7
10
|
| 2014 |
45
41
31
|
| 2013 |
Open access
7
3
|
| 2013 |
Open access
46
33
|
| 2012 |
Open access
45
43
|
| 2012 |
25
24
|
| 2011 |
72
70
|
| 2010 |
7
7
|
| 2010 |
3
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Calistoga Pharmaceuticals Inc. | UNITED STATES |
| Chris O'Brien Lifehouse | AUSTRALIA |
| Clinpath Pathology | AUSTRALIA |
| Coopers Brewery | AUSTRALIA |
| Coopers Brewery Limited | AUSTRALIA |
| Flinders University | AUSTRALIA |
| Griffith University | AUSTRALIA |
| Ludwig Institute for Cancer Research | AUSTRALIA |
| Macquarie University | AUSTRALIA |
| Monash Medical Centre | AUSTRALIA |
| Monash University | AUSTRALIA |
| Murdoch Childrens Research Institute | AUSTRALIA |
| Queen Mary University of London | UNITED KINGDOM |
| Royal Adelaide Hospital | AUSTRALIA |
| Royal Prince Alfred Hospital | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| Thammasat University | THAILAND |
| Tubingen University Hospital | GERMANY |
| University of Adelaide | AUSTRALIA |
| University of Applied Sciences and Arts Northwestern Switzerland | SWITZERLAND |
| University of Erlangen-Nuremberg | GERMANY |
| University of Gothenburg | SWEDEN |
| University of Manchester | UNITED KINGDOM |
| University of Melbourne | AUSTRALIA |
| University of New South Wales | AUSTRALIA |
| University of Science, Malaysia | MALAYSIA |
| University of South Australia | AUSTRALIA |
| University of Washington | UNITED STATES |
| University of Western Australia | AUSTRALIA |
| Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
| Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
Winnovation Awards ScienceDepartment of Environment and Water |
2020 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Advancing Protein Therapeutic Development | Current |
| Functional Analysis and Quantification of Biopharmaceuticals in Tissues by Mass Spectrometry Imaging | Current |
| Linking the intracellular journey of gold nanoparticles to protein expression changes in prostate cancer cells | Current |
| Maximising yeast health during the industrial beer brewing process: a proteomics investigation | Current |
| Overcoming the hurdles of drug delivery for ovarian cancer: Preparation of targeted and pH-responsive nanoparticles loaded with Kinase and PARP Inhibitors. | Current |
| Towards personalised treatment of Ovarian Cancer | Current |
